Study Evaluating SC262 in Subjects With r/r B-cell Malignancies (VIVID)

Conditions: Non Hodgkin ' s Lymphoma; Large B-cell Lymphoma Interventions: Drug: SC262 Sponsors: Sana Biotechnology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials